Tag Archives: business news

January, 2017

  • 9 January

    Amgen and Immatics Partner To Develop Novel Bispecific Cancer Immunotherapies

    THOUSAND OAKS, Calif. and TUEBINGEN, Germany, Jan. 9, 2017 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Immatics Biotechnologies GmbH, a leading company in the field of cancer immunotherapy, today announced a research collaboration and exclusive license agreement to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers. The collaboration will combine Immatics’ world-leading …

  • 9 January

    Ipsen to Acquire Oncology Assets from Merrimack

    CAMBRIDGE, Mass., Jan. 8, 2017 /PRNewswire/ — Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) (“Merrimack” or the “Company”) today announced that it has entered into a definitive asset purchase and sale agreement with Ipsen (Euronext: IPN; ADR: IPSEY) for a transaction valued at up to $1.025 billion, plus up to $33 million in …

  • 4 January

    Jounce Therapeutics Files for $75M IPO

    CAMBRIDGE, Mass., January 3, 2017 –Jounce Therapeutics, a clinical-stage immuno-oncology company, has filed an initial public offering  through which it hopes to raise $75 million in 2017. The Cambridge, MA-based company was founded in 2012 and employs a two-pronged approach to therapy development: using a translational science platform that targets …

July, 2015

  • 8 July

    Horizon Pharma Offers to Acquire Depomed in a $3 Billion Deal

    DUBLIN, IRELAND — (Marketwired) — 07/07/15 — Horizon Pharma plc (NASDAQ: HZNP) Transaction would generate significant revenue and operating synergies, tax savings and would also be immediately and substantially accretive to Horizon’s adjusted diluted earnings per share Projected full-year pro forma combined 2015 net sales and adjusted EBITDA would be …